1. Home
  2. KRMD vs EARN Comparison

KRMD vs EARN Comparison

Compare KRMD & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$4.08

Market Cap

192.5M

Sector

Health Care

ML Signal

HOLD

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$4.40

Market Cap

169.8M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
EARN
Founded
1980
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
192.5M
169.8M
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
KRMD
EARN
Price
$4.08
$4.40
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$6.50
$5.38
AVG Volume (30 Days)
126.2K
371.2K
Earning Date
05-06-2026
06-16-2026
Dividend Yield
N/A
20.51%
EPS Growth
53.85
N/A
EPS
N/A
N/A
Revenue
$41,127,366.00
N/A
Revenue This Year
$20.32
$7.69
Revenue Next Year
$17.37
$19.57
P/E Ratio
N/A
N/A
Revenue Growth
22.23
N/A
52 Week Low
$3.20
$4.27
52 Week High
$6.61
$6.06

Technical Indicators

Market Signals
Indicator
KRMD
EARN
Relative Strength Index (RSI) 46.56 50.46
Support Level $3.86 $4.43
Resistance Level $4.26 $4.46
Average True Range (ATR) 0.20 0.08
MACD -0.05 0.01
Stochastic Oscillator 34.45 94.12

Price Performance

Historical Comparison
KRMD
EARN

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co The Fund is focused on acquiring and actively managing a portfolio of corporate CLOs, mainly mezzanine debt and equity tranches, which are typically collateralized by portfolios consisting mainly of below-investment-grade senior secured loans with a large number of discrete underlying borrowers across various industry sectors. Additionally, the Fund may also invest in CLO loan accumulation facilities, which are entities that acquire corporate loans and other similar corporate credit-related assets in anticipation of ultimately collateralizing a CLO transaction. The company's primary investment objectives are to generate attractive current income and risk-adjusted total returns for shareholders.

Share on Social Networks: